Good for you! I’d just remove ROW approvals from your expectations. It comes across as naive, particularly ones that understand the healthcare business around the world! ;) Both KA and LL will want to make the vaccine available worldwide and that’s great, but from a business perspective it doesn’t make much sense for NWBO to fight that battle over the next 3-5 years. Unless you have another 10 year vision for NWBO! ;)
Let’s hope the NWBO management team delivers on your Project Orbis expectations! Either way, I am hopeful (like you) that we will receive UK, US, Canada and EU approvals. Timing of UK approvals look like Q1/Q2 2023, but others I am not so sure because management hasn’t provided any clue to us yet.